Clara Liao
PhD student; neuroscientist
Data updated
Research Footprint
Clara Liao appears in 5 tracked papers (2021–2026), most studied alongside Psilocybin, Ketamine and 5-MeO-DMT, across Depressive Disorders, Neuroimaging & Brain Measures and Obsessive-Compulsive Disorder (OCD).
Most-cited paper: Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors (67 citations).
Frequent co-authors: Alex Kwan.
Background & Research
Clara Liao is a Yale-trained neuroscientist who completed her PhD work in the Interdepartmental Neuroscience Program under Alex Kwan. Her research has focused on the neurobiological mechanisms underlying psilocybin’s therapeutic and neuroplasticity-promoting actions, including dendritic spine growth, pyramidal-cell dependence, and interneuron-specific effects. She also has a strong interest in science communication and has produced public-facing neuroscience explainers.
Key Impact
Clara Liao is notable for coauthoring multiple influential Yale/Kwan lab papers on psilocybin’s structural and cell-type-specific effects in the brain.
Collaboration Network
1 collaborator· click a node to visit their profile
Full network →